首頁 > 市場調查報告書 > 醫療設備

纖維

市場調查報告書

商品編碼

1529386

全球生物醫用紡織品市場 - 2024-2031

Global Biomedical textiles market - 2024-2031

出版日期: 2024年08月06日 | 出版商:

DataM Intelligence | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

2023年，全球生物醫用紡織品市場達到178億美元，預計2031年將達288億美元，2024-2031年預測期間複合年成長率為6.2%。

生物醫用紡織品是基於纖維的醫療設備，可以植入患者體內以恢復組織特性，提供機械支撐，並促進各種適應症的癒合過程。以織物為基礎的植入式醫療器材包括但不限於縫線、網片、血管移植物和心臟瓣膜。

生物醫學紡織品可以由合成或天然來源製成，並且根據醫療器械的預期用途可以是不可再吸收的或可再吸收的。生物醫學紡織品可以透過四種主要加工方法建構：針織、機織、編織和非織造方法。

生物醫學紡織品市場涉及專門為醫學和生物應用設計的紡織品的生產和使用。這些紡織品用於各種醫療領域，包括傷口護理、植入物、手術縫線和醫療保健織物。它們經過精心設計，可與生物系統相互作用，並具有生物相容性、抗菌特性、耐用性以及促進癒合和組織再生的能力等性能特徵。

市場動態：

司機

人口老化加劇、慢性病盛行率增加、外科手術數量增加

全球生物醫用紡織品市場的需求受到多重因素驅動。人口老化的不斷加劇、慢性病的流行以及外科手術數量的增加也促進了市場的擴大。

全球不斷成長的老齡化人口正在推動對醫療保健服務和產品的需求。隨著老年人口的增加，對傷口護理、矯形支持和其他適應年齡相關狀況的生物醫學紡織品的需求更大。此外，糖尿病和心血管疾病等慢性病的流行進一步推動了對用於傷口管理和治療的生物醫用紡織品的需求。

此外，關鍵參與者的策略（例如夥伴關係和協作）將推動該市場的成長。例如，2022年4月，Integer Holdings Corporation宣布收購Connemara Biomedical Holdings Teoranta，包括其營運子公司Aran Biomedical及Proxy Biomedical。透過利用符合我們策略的此次收購，與Aran 的合併進一步增強了Integer 為高成長心血管市場（如結構性心臟、神經血管、周邊血管和血管內以及普通外科）的複雜輸送和治療設備提供完整解決方案的能力。

手術數量的增加和對高品質傷口敷料材料的需求預計將推動生物醫用紡織品市場。使用生物醫用紡織品可以治療受損的組織或器官，這是與生物醫用紡織品相關的先進醫學發明的結果。

限制

高研發投資、原料短缺、個人缺乏意識以及監管挑戰等因素預計將阻礙市場發展。

有關此報告的更多詳細資訊 - 索取樣本

Biomedical textiles are fiber-based medical devices that can be implanted in patients to restore tissue properties, provide mechanical support, as well as facilitate the healing process for a variety of indications. Textile-based implantable medical devices include but are not limited to sutures, meshes, vascular grafts, and heart valves.

Biomedical textiles may be created from synthetic or natural sources and may be non-resorbable or resorbable based on the medical device's intended use. Biomedical textiles may be constructed by four main processing methods knitting, weaving, braiding, and non-woven methods.

The biomedical textiles market involves the production and use of textile products designed specifically for medical and biological applications. These textiles are used in various medical fields, including wound care, implants, surgical sutures, and healthcare fabrics. They are engineered to interact with biological systems and are designed for performance characteristics such as biocompatibility, antimicrobial properties, durability, and the ability to promote healing and tissue regeneration.

Market Dynamics: Drivers

Growing aging population & prevalence of chronic diseases and rising number of surgical procedures

The demand for the global biomedical textiles market is driven by multiple factors. The growing aging population & the prevalence of chronic diseases and the rising number of surgical procedures are also contributing to the expansion of the market.

The growing aging population globally is driving the demand for healthcare services and products. As the elderly population increases, there is a greater need for wound care, orthopedic support, and other biomedical textiles that cater to age-related conditions. In addition, the prevalence of chronic diseases, such as diabetes and cardiovascular diseases, further fuels the demand for biomedical textiles for wound management and treatment.

Moreover, key players' strategies such as partnerships & collaborations would drive this market growth. For instance, in April 2022, Integer Holdings Corporation announced the acquisition of Connemara Biomedical Holdings Teoranta, including its operating subsidiaries Aran Biomedical and Proxy Biomedical. By using this acquisition consistent with our strategy, the combination with Aran further increases Integer's ability to offer complete solutions for complex delivery and therapeutic devices in high-growth cardiovascular markets such as structural heart, neurovascular, peripheral vascular, and endovascular as well as general surgery.

The increasing number of surgeries and the demand for high-quality wound dressing material are expected to drive the biomedical textiles market. With the use of biomedical textiles, damaged tissues or organs can be treated, which is a result of advanced medical inventions related to biomedical textiles.

Restraints

Factors such as high R&D investments, shortages of raw materials, lack of awareness among individuals, and regulatory challenges are expected to hamper the market.

For more details on this report - Request for Sample

Segment Analysis

The global biomedical textiles market is segmented based on fiber, fabric, application, and region.

The non-biodegradable fiber segment accounted for approximately 56.6% of the global biomedical textiles market share

The non-biodegradable fiber segment is expected to hold the largest market share over the forecast period. These are the fibers that are not degraded by biological conditions for a long time and are mostly used for external purposes. These include polytetrafluoroethylene (PTFE), polyester, polypropylene, carbon, and others. Non-biodegradable fibers are used for applications where long-lasting performance is required, such as in surgical sutures, wound dressings, and implantable devices.

These sutures provide the necessary support to hold tissues together during the healing process, making them indispensable in surgical procedures. Their resistance to degradation ensures that they maintain structural integrity in medical applications, which is critical for patient safety and efficacy of treatment.

In addition, key players in the industry's innovative developments propel this segment's growth. For instance, in August 2022, The RGE-NTU SusTex project aims to accelerate innovation in textile recycling and translate research outcomes into practical solutions that can be deployed in urban settings like Singapore. Researchers in the S$6m joint research center will look into areas such as next-generation eco-friendly and sustainable textiles and refabricating textile waste into fiber. The aim is to study the chemistry of various textile materials and determine the optimal processes and techniques required to start a circular textile economy.

Geographical Analysis

North America accounted for approximately 45.7% of the global biomedical textiles market share

North America region is expected to hold the largest market share over the forecast period increasing the prevalence of chronic diseases, advancements in healthcare technology, and well-established healthcare infrastructure help to drive this market growth.

According to the National Institutes of Health, in June 2023, a significant portion of the U.S. population suffered from conditions requiring advanced medical interventions, which in turn drives the demand for biomedical textiles. For instance, the growing number of surgeries related to obesity and cardiovascular issues necessitates the use of specialized textiles for surgical applications.

Moreover, a major number of key players' presence and key developments in biomedical textiles propel this market growth in this region. For instance, in March 2024, Integra LifeSciences Holdings Corporation announced that MicroMatrix Flex is now available commercially in the U.S. MicroMatrix Flex is a dual-syringe system enabling the convenient mixing and precise delivery of MicroMatrix paste to provide convenient access to hard-to-reach spaces and to help prepare an even wound surface in challenging wound areas.

Also, in October 2022, Cortland Biomedical unveiled new capabilities for creating textile structures incorporating radiopaque fibers. Incorporating radiopaque fibers into diagnostic and interventional medical devices enables the devices to become visible under fluoroscopy.

Market Segmentation

By Fiber

Non-biodegradable Fiber
Biodegradable Fiber
Others

By Fabric

Woven
Non-woven
Others

By Application

Implantable
Non-implantable
Surgical Sutures
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- The rest of South America
Asia-Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Middle East and Africa

Competitive Landscape

The major global players in the biomedical textiles market include Bally Ribbon Mills, Medical Murray, Indorama Corporation, Confluent Medical Technologies, ARAN BIOMEDICAL TEORANTA, Poly-Med Incorporated, CORTLAND BIOMEDICAL, Secant Group, Integer Holdings Corporation and Swicofil AG among others.

Key Developments

In June 2023, AccYouRate launched a smart T-shirt capable of providing real-time online monitoring of the body's vital signals. The 100% textile e-shirt measures ECG (including heart rate), breathing frequency and depth, body temperature, accelerometer, GPS, and body position, which enables fall alerts.
In February 2021, Ahlstrom-Munksjo launched a new product portfolio, which consists of a full suite of fabrics for medical and civil use face masks, including biodegradable and compostable materials such as PLA and cellulosic. The TenderGuard product portfolio consists of exceptionally soft, comfortable, and protective fabrics including TenderGuard BioBased and BioFilter fabrics, which are designed for civil use and source control for infectious diseases.

Why Purchase the Report?

To visualize the global biomedical textiles market segmentation based on fiber, fabric, application, and region and understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of the biomedical textiles market with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping is available in Excel consisting of key products of all the major players.

The global biomedical textiles market report would provide approximately 62 tables, 53 figures, and 183 pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Fiber
3.2. Snippet by Fabric
3.3. Snippet by Application
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Aging Population & Prevalence of Chronic Diseases and Rising Number of Surgical Procedures
  - 4.1.1.2. Growing Need for High-Quality Wound Dressing Material
- 4.1.2. Restraints
  - 4.1.2.1. High R&D Investments
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis

6. By Fiber

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
- 6.1.2. Market Attractiveness Index, By Fiber
6.2. Non-biodegradable Fiber *
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Biodegradable Fiber
6.4. Others

7. By Fabric

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
- 7.1.2. Market Attractiveness Index, By Fabric
7.2. Woven*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Non-woven
7.4. Others

8. By Application

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Market Attractiveness Index, By Application
8.2. Implantable *
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Non-implantable
8.4. Surgical Sutures
8.5. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. U.S.
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. U.K.
  - 9.3.6.3. France
  - 9.3.6.4. Spain
  - 9.3.6.5. Italy
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. South Korea
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fiber
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Fabric

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. Bally Ribbon Mills *
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Medical Murray
11.3. Indorama Corporation
11.4. Confluent Medical Technologies
11.5. ARAN BIOMEDICAL TEORANTA
11.6. Poly-Med Incorporated
11.7. CORTLAND BIOMEDICAL
11.8. Secant Group
11.9. Integer Holdings Corporation
11.10. Swicofil AG

LIST NOT EXHAUSTIVE